Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung Yu

Showing results (621-630 of 643) with videos related to

Pageof 65
Sort By:
The Prostate|February 20, 2024
A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancerPei-Chen Ye, Wohn-Jenn Leu, Tsung-Yu Yeh, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 25, 2021
Multifunctional Ion-Sensitive Floating Gate Fin Field-Effect Transistor with Three-Dimensional Nanoseaweed Structure by Glancing Angle Deposition TechnologyYing-Chun Shen, Chien-Ping Wang, Kun-Lin Liou, et al.
Health and Quality of Life Outcomes|December 21, 2019
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scalingHélène E Aschmann, Milo A Puhan, Craig W Robbins, et al.
Microbiology Spectrum|January 5, 2023
Subcellular Distribution of BALF2 and the Role of Rab1 in the Formation of Epstein-Barr Virus Cytoplasmic Assembly Compartment and Virion ReleaseTsung-Yu Chao, Yi-Ying Cheng, Zi-Yun Wang, et al.
Acta Cardiologica Sinica|January 29, 2026
Rationale, Objectives and Study Design of the Taiwan Registry of Hypertrophic Cardiomyopathy (THIC)Yen-Wen Wu, Wen-Chung Yu, Chung-Lieh Hung, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural MetastasesMuh-Lii Liang, Ting-Chi Yeh, Man-Hsu Huang, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
American Journal of Cancer Research|January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapiesWei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
American Journal of Cancer Research|March 10, 2023
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapyWei-Fan Hsu, Hsueh-Chou Lai, Cheng-Kuo Chen, et al.
Pageof 65

Showing results (621-630 of 643) with videos related to

Sort By:
Pageof 65
The Prostate|February 20, 2024
A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancerPei-Chen Ye, Wohn-Jenn Leu, Tsung-Yu Yeh, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 25, 2021
Multifunctional Ion-Sensitive Floating Gate Fin Field-Effect Transistor with Three-Dimensional Nanoseaweed Structure by Glancing Angle Deposition TechnologyYing-Chun Shen, Chien-Ping Wang, Kun-Lin Liou, et al.
Health and Quality of Life Outcomes|December 21, 2019
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scalingHélène E Aschmann, Milo A Puhan, Craig W Robbins, et al.
Microbiology Spectrum|January 5, 2023
Subcellular Distribution of BALF2 and the Role of Rab1 in the Formation of Epstein-Barr Virus Cytoplasmic Assembly Compartment and Virion ReleaseTsung-Yu Chao, Yi-Ying Cheng, Zi-Yun Wang, et al.
Acta Cardiologica Sinica|January 29, 2026
Rationale, Objectives and Study Design of the Taiwan Registry of Hypertrophic Cardiomyopathy (THIC)Yen-Wen Wu, Wen-Chung Yu, Chung-Lieh Hung, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural MetastasesMuh-Lii Liang, Ting-Chi Yeh, Man-Hsu Huang, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
American Journal of Cancer Research|January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapiesWei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
American Journal of Cancer Research|March 10, 2023
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapyWei-Fan Hsu, Hsueh-Chou Lai, Cheng-Kuo Chen, et al.
Pageof 65